We are finally able to prove the statistically significant improvement in ds at 10 weeks in the whole sample and to show the correct outcome.
the editor Current Oncology June 20, 2012 hanna et al. 1 investigated the improvement in dysphagia score (ds) in inoperable esophageal cancer treated with endoluminal stenting or radiation therapy. They defined ds ≤ 1 at the 10-week follow-up mark as acceptable resolution of dysphagia, and they claimed a statistically significant improvement in the whole sample and in both treatment groups. the paper is interesting, but there is a weak point in the statistical analysis that could affect the results, because they compared paired data (rate of patients with ds = 1 at presentation versus rate of patients with ds ≤ 1 in follow-up) using the Fisher test instead of the McNemar test 2 .
the authors reported only percentages and not numbers of patients associated to ds levels, but using some math skills and knowledge of the McNemar test formula, we gather the correct result from the available information for the whole sample.
Let's define the standard 2×2 contingency table used with the McNemar test:
• A is the number of subjects with ds ≤ 1 both at presentation and at 10 weeks • B is the number of subjects with ds ≤ 1 at presentation and ds > 1 at 10 weeks ("aggravations") • C is the number of subjects with ds > 1 at presentation and ds ≤ 1 at 10 weeks ("improvements") • D is the number of subjects with ds > 1 both at presentation and at 10 weeks 
